Steven Cohen (Trades, Portfolio) of Point72 Asset Management recently added three new positions to his portfolio, according to GuruFocus Real TIme Picks. Cohen's portfolio currently consists of 644 stocks, valued at $14.25 billion and a quarter over quarter turnover of 53%.
The most heavily weighted sector in Cohen's portfolio is the consumer cyclical sector, which consists of 21.6% of his overall portfolio. Next is the energy sector, which consists of 16.7% and technology consists of 14.5%.
Here's a look at Cohen's latest purchases:
RetailMeNot Inc (SALE, Financial)
Cohen purchased 2,924,519 shares of SALE at an average price of $15.40 a share.
RetailMeNot is a digital coupon marketplace that allows consumers to search for, discover and redeem digital coupons from various retailers and brands in clothing, electronics, health, beauty, home and office, travel, food and entertainment, personal and business services, as well as shoes.
The stock is currently trading at $18.11 a share. The Peter Lynch earnings line is at $14.60, which indicates the stock may be overvalued.
Earnings per share for the trailing 12 months as of September 2014 was $0.37. The P/E ratio is currently 49.35.
Revenue per share for the trailing 12 months was $4.47. The P/S ratio is currently 4.05 and ranked higher than 54% of the companies in the global marketing industry.
The P/B ratio is currenly 2.02.
Healthways Inc (HWAY, Financial)
Cohen purchased 2,316,700 shares of HWAY at an average price of $21.51 a share.
The company provides specialized solutions to help individuals improve their well-being. Wellness and disease prevention solutions are also offered through population screenings, well-being assessments and interventions.
The Peter Lynch earnings line is at $9.40, which indicates the stock may be overvalued as it is currently trading at $22.32 a share.
The current P/S ratio is 1.11. The P/S ratio is close to the five-year high of 1.13, which is a warning sign investors should be aware of.
Revenue per share for the trailing 12 months was $20.06, with a growth rate of 3.50%. Another warning sign investors should be aware of is the company's revenue has been in decline over the past three years. The growth rate for the past three years was -2.30% a year.
Five Prime Therapeutics Inc (FPRX, Financial)
Cohen purchased 1,270,352 shares of FPRX at an average price of $24.89
FPRX is currently trading at $24.75 a share. The P/B ratio is 5.66 and investors should be warned that it is close to the two-year high of 6.28.
The P/S ratio is currently 27.15 and investors should also be warned that it is close to the two-year high of 30.12.
One positive is the company currently has no debt. We gave the company a Financial Strength ranking 8 out 10.
Cohen also increased stakes in the following positions: Lumber Liquidators Holdings Inc (LL, Financial), Visteon Corp (VC, Financial), ZELTIQ Aesthetics Inc (ZLTQ, Financial), Shutterfly Inc (SFLY, Financial), Kraton Performance Polymers Inc (KRA, Financial), Walter Investment Management Corp (WAC, Financial), RCS Capital Corp (RCAP, Financial), Jones Energy Inc (JONE, Financial) and Crocs Inc (CROX).
Cohen reduced his stakes in the following positions: Clearwater Paper Corp (CLW), Silicon Motion Technology Corp (SIMO) and Kindred Healthcare Inc (KND).
To view the portfolios of more gurus, visit the List of Gurus page. Not a premium member of GuruFocus? Try it free for 7 days.
